A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
Titel:
A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas
Auteur:
Infante, Jeffrey R. Somer, Bradley G. Park, Joon Oh Li, Chung-Pin Scheulen, Max E. Kasubhai, Saifuddin M. Oh, Do-Youn Liu, Yuan Redhu, Suman Steplewski, Klaudia Le, Ngocdiep